These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19915484)

  • 1. Diagnostic use of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues.
    Horbinski C; Kofler J; Kelly LM; Murdoch GH; Nikiforova MN
    J Neuropathol Exp Neurol; 2009 Dec; 68(12):1319-25. PubMed ID: 19915484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the rapid Idylla IDH1-2 mutation assay in FFPE glioma samples.
    Solomon JP; Munoz-Zuluaga C; Slocum C; Dillard A; Cong L; Wang J; Lindeman N; Kluk M; Liechty B; Pisapia D; Rennert H; Velu PD
    Diagn Pathol; 2024 May; 19(1):70. PubMed ID: 38796421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of IDH1 and IDH2 mutations in Japanese glioma patients.
    Sonoda Y; Kumabe T; Nakamura T; Saito R; Kanamori M; Yamashita Y; Suzuki H; Tominaga T
    Cancer Sci; 2009 Oct; 100(10):1996-8. PubMed ID: 19765000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of IDH1 and IDH2 mutations by fluorescence melting curve analysis as a diagnostic tool for brain biopsies.
    Horbinski C; Kelly L; Nikiforov YE; Durso MB; Nikiforova MN
    J Mol Diagn; 2010 Jul; 12(4):487-92. PubMed ID: 20431032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma.
    Catteau A; Girardi H; Monville F; Poggionovo C; Carpentier S; Frayssinet V; Voss J; Jenkins R; Boisselier B; Mokhtari K; Sanson M; Peyro-Saint-Paul H; Giannini C
    Acta Neuropathol Commun; 2014 Jun; 2():58. PubMed ID: 24889502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Evaluation of IDH Mutation Status in Formalin-Fixed Paraffin-Embedded Tissue in Gliomas.
    Nelson EJ; Gubbiotti MA; Carlin AM; Nasrallah MP; Van Deerlin VM; Herlihy SE
    Mol Diagn Ther; 2023 May; 27(3):371-381. PubMed ID: 36690887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular investigation of isocitrate dehydrogenase gene (IDH) mutations in gliomas: first report of IDH2 mutations in Indian patients.
    Das BR; Tangri R; Ahmad F; Roy A; Patole K
    Asian Pac J Cancer Prev; 2013; 14(12):7261-4. PubMed ID: 24460285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of IDH1 and IDH2 Mutation in Formalin-fixed Paraffin-embedded Gliomas Using Allele-specific COLD-PCR and Probe Melting Curve Analysis.
    Zhang Q; Liu K; Yang W; Shao W; Liu D; Lan H; Ji T
    Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):e93-e100. PubMed ID: 30299371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive and rapid detection of TERT promoter and IDH mutations in diffuse gliomas.
    Diplas BH; Liu H; Yang R; Hansen LJ; Zachem AL; Zhao F; Bigner DD; McLendon RE; Jiao Y; He Y; Waitkus MS; Yan H
    Neuro Oncol; 2019 Mar; 21(4):440-450. PubMed ID: 30346624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas.
    Houdova Megova M; Drábek J; Dwight Z; Trojanec R; Koudeláková V; Vrbková J; Kalita O; Mlcochova S; Rabcanova M; Hajdúch M
    Klin Onkol; 2017; 30(5):361-371. PubMed ID: 29031038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations.
    Jin G; Reitman ZJ; Spasojevic I; Batinic-Haberle I; Yang J; Schmidt-Kittler O; Bigner DD; Yan H
    PLoS One; 2011 Feb; 6(2):e16812. PubMed ID: 21326614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IDH1 and IDH2 mutations in gliomas.
    Yan H; Parsons DW; Jin G; McLendon R; Rasheed BA; Yuan W; Kos I; Batinic-Haberle I; Jones S; Riggins GJ; Friedman H; Friedman A; Reardon D; Herndon J; Kinzler KW; Velculescu VE; Vogelstein B; Bigner DD
    N Engl J Med; 2009 Feb; 360(8):765-73. PubMed ID: 19228619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and sensitive intraoperative detection of mutations in the isocitrate dehydrogenase 1 and 2 genes during surgery for glioma.
    Kanamori M; Kikuchi A; Watanabe M; Shibahara I; Saito R; Yamashita Y; Sonoda Y; Kumabe T; Kure S; Tominaga T
    J Neurosurg; 2014 Jun; 120(6):1288-97. PubMed ID: 24745708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas.
    Chou AP; Chowdhury R; Li S; Chen W; Kim AJ; Piccioni DE; Selfridge JM; Mody RR; Chang S; Lalezari S; Lin J; Sanchez DE; Wilson RW; Garrett MC; Harry B; Mottahedeh J; Nghiemphu PL; Kornblum HI; Mischel PS; Prins RM; Yong WH; Cloughesy T; Nelson SF; Liau LM; Lai A
    J Natl Cancer Inst; 2012 Oct; 104(19):1458-69. PubMed ID: 22945948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of the occurrence rates of
    Cho U; Yang SH; Yoo C
    J Int Med Res; 2021 Jun; 49(6):3000605211019258. PubMed ID: 34162262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
    Hartmann C; Meyer J; Balss J; Capper D; Mueller W; Christians A; Felsberg J; Wolter M; Mawrin C; Wick W; Weller M; Herold-Mende C; Unterberg A; Jeuken JW; Wesseling P; Reifenberger G; von Deimling A
    Acta Neuropathol; 2009 Oct; 118(4):469-74. PubMed ID: 19554337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel COLD-PCR/FMCA assay enhances the detection of low-abundance IDH1 mutations in gliomas.
    Pang B; Durso MB; Hamilton RL; Nikiforova MN
    Diagn Mol Pathol; 2013 Mar; 22(1):28-34. PubMed ID: 23370430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining IDH-Mutational Status in Gliomas Using IDH1-R132H Antibody and Polymerase Chain Reaction.
    Gondim DD; Gener MA; Curless KL; Cohen-Gadol AA; Hattab EM; Cheng L
    Appl Immunohistochem Mol Morphol; 2019; 27(10):722-725. PubMed ID: 30358614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Polymerase Chain Reaction-Restriction Fragment Length Polymorphism, Immunohistochemistry, and DNA Sequencing for the Detection of IDH1 Mutations in Gliomas.
    Malueka RG; Theresia E; Fitria F; Argo IW; Donurizki AD; Shaleh S; Innayah MR; Wicaksono AS; Dananjoyo K; Asmedi A; Hartanto RA; Dwianingsih EK
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3229-3234. PubMed ID: 33247679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDH mutation detection in formalin-fixed paraffin-embedded gliomas using multiplex PCR and single-base extension.
    Perizzolo M; Winkfein B; Hui S; Krulicki W; Chan JA; Demetrick DJ
    Brain Pathol; 2012 Sep; 22(5):619-24. PubMed ID: 22360629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.